Biomerica Aktie - BMRA

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,6698

Gebot

0,63

Fragen

0,6698

Volumen

163.577

0,61 Tagesbereich 0,6566

0,2415 52-Wochen-Bereich 1,27

Marktkapitalisierung

12,282M

Handelsende

0,6496

Handelsbeginn

0,632501

Letzte Trade

0.6697

Letzter Handelszeitpunkt

Finanzvolumen

US$ 102.886

VWAP

0,628975

Durchschnittliches Volumen (3 Mio.)

8.464.108

Ausgegebene Aktien

18.336.994

Dividendenrendite

Kurs-Gewinn-Verhältnis

-1,96

Gewinn pro Aktie (EPS)

-0,33

Erlöse

5,42M

Nettogewinn

-5,98M

Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain es... Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the company's revenue is earned from the Europe market. Mehr anzeigen

Sektor

In Vitro,in Vivo Diagnostics

Branche

In Vitro,in Vivo Diagnostics

Website

www.biomerica.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Biomerica Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker BMRA. The last closing price for Biomerica was US$0,65. Over the last year, Biomerica shares have traded in a share price range of US$ 0,2415 to US$ 1,27.

Biomerica currently has 18.336.994 shares in issue. The market capitalisation of Biomerica is US$11,91 million. Biomerica has a price to earnings ratio (PE ratio) of -1.96.

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring...

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

- 10-Minute PSA Test for Early Detection of Prostate Specific Antigen (PSA), an Early Warning Sign of Prostate...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.0532	-7.35822959889	0.723	0.7699	0.64	271084	0.69428612	CS
4	0.1108	19.8211091234	0.559	1.1	0.5011	1452210	0.80568329	CS
12	0.3728	125.521885522	0.297	1.27	0.26	8464108	0.70154979	CS
26	0.3332	98.9898989899	0.3366	1.27	0.26	4164541	0.66551523	CS
52	-0.4902	-42.2586206897	1.16	1.27	0.2415	2207848	0.65240869	CS
156	-3.4602	-83.7820823245	4.13	5.25	0.2415	897672	0.89965391	CS
260	-2.4402	-78.463022508	3.11	23.39	0.2415	832837	3.20828336	CS

BMRA - Frequently Asked Questions (FAQ)

What is the current Biomerica share price?

The current share price of Biomerica is US$ 0,6698

How many Biomerica shares are in issue?

Biomerica has 18.336.994 shares in issue

What is the market cap of Biomerica?

The market capitalisation of Biomerica is USD 11,91M

What is the 1 year trading range for Biomerica share price?

Biomerica has traded in the range of US$ 0,2415 to US$ 1,27 during the past year

What is the PE ratio of Biomerica?

The price to earnings ratio of Biomerica is -1,96

What is the cash to sales ratio of Biomerica?

The cash to sales ratio of Biomerica is 2,17

What is the reporting currency for Biomerica?

Biomerica reports financial results in USD

What is the latest annual turnover for Biomerica?

The latest annual turnover of Biomerica is USD 5,42M

What is the latest annual profit for Biomerica?

The latest annual profit of Biomerica is USD -5,98M

What is the registered address of Biomerica?

The registered address for Biomerica is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Biomerica website address?

The website address for Biomerica is www.biomerica.com

Which industry sector does Biomerica operate in?

Biomerica operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
CAPSCapstone Holding Corp	US$ 3,50 (1.300,00%)	36,33k
ABLVAble View Global Inc	US$ 1,73 (137,18%)	5,13M
SUNESUNation Energy Inc	US$ 0,402999 (127,55%)	476,73M
BTOGBit Origin Ltd	US$ 0,6117 (118,46%)	618,03M
DWTXDogwood Therapeutics Inc	US$ 6,63 (49,66%)	25,77M
ALBTAvalon GloboCare Corporation	US$ 6,96 (-36,15%)	577,55k
SCNXScienture Holdings Inc	US$ 1,55 (-35,68%)	1,59M
ACXPAcurx Pharmaceuticals Inc	US$ 0,4572 (-29,88%)	1,18M
RETOReTo Eco Solutions Inc	US$ 5,42 (-27,73%)	108,27k
OCTOEightco Holdings Inc	US$ 1,08 (-27,03%)	336,99k
BTOGBit Origin Ltd	US$ 0,6117 (118,46%)	622,67M
SUNESUNation Energy Inc	US$ 0,402999 (127,55%)	482,05M
NVDANVIDIA Corporation	US$ 112,69 (1,92%)	341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10,675 (-0,70%)	143,04M
ICONIcon Energy Corporation	US$ 0,169898 (17,17%)	142,23M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Biomerica Inc (BMRA) Börsenkurse

Biomerica Inc (BMRA)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Biomerica Inc

BMRA Neueste Nachrichten

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

BMRA - Frequently Asked Questions (FAQ)

Beweger

BMRA Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen